← Back

$ Value

$0

Shares

36,101

Price

$0

Filed

Jul 2

Insider

Name

Meury William

Title

Chief Executive Officer

CIK

0001536778

Roles

Director Officer Other

Transaction Details

Transaction Date

2025-07-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

36,101

Footnotes

Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. | Includes the July 2, 2025 aggregate grant of 36,101 shares of common stock. | Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. | Each performance share represents the right to receive up to 400% of one share of common stock. The number of shares that may be earned and vested is contingent on the achievement of pre-established performance and vesting conditions over a six-year performance period, as described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on June 27, 2025.

Filing Info

Accession No.

0000879169-25-000067

Form Type

4

Issuer CIK

0000879169

Meury William's History

Date Ticker Type Value
2026-04-15 INCY M $0
2025-07-02 INCY A $0
2025-07-02 INCY A $0
2025-07-02 INCY A $0
2025-06-26 INCY A $0

Other Insiders at INCY (90d)

Insider Bought Sold Last
HARRIGAN EDMUND 2026-03-31
CAGNONI PABLO J
President, Global Head of R&D
$1.8M 2026-04-17
BAKER BROS. ADVISORS LP 2026-03-31
Clancy Paul J 2026-03-31
Meury William
Chief Executive Officer
2026-04-15
Stein Steven H
CMO & Head of Late-Stage Dev.
2026-04-15
Trotta Matteo
EVP, GM, Dermatology US
2026-03-25